Epsilon Healthcare Ltd (epn) Logo

Epsilon Healthcare Ltd (EPN)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

EPN Chart

Snapshot

EPN's Principal Activity is the the Group plans to be a worldwide manufacturer and distributor of hydroponics equipment, materials and nutrients; and leader in the development and delivery of medicinal cannabis.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -75.81%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 2,265 of 2,420
Sector Rank 200 of 210

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies FFC / ALT / ICR
EPS -$0.048
DPS $0.00
Book Value Per Share $0.09

Broker Consensus

EPN is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Corporate Overview

Epsilon Healthcare Limited (EPN, formerly THC Global Group Limited) is a diversified global cannabis company with primary operations in Australia and Canada. EPN owns and operates end to end commercial medicinal cannabis production facilities under Australia's cannabis regulations. EPN also owns and operates a turnkey cultivation solutions provider, including a hydroponics equipment and supplies wholesaler and retailer servicing the rapidly expanding cannabis sectors in North America and Europe.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Sydney NSW 2000
Website www.epsilonhealthcare.com.au
Registry Computershare
Auditor RSM Australia Partners
Date Listed 4 May 2017

Upcoming Calendar (Forecasted)

Date Event
30/08/2022 Report (Interim)
28/02/2023 Report (Prelim)
31/03/2023 Report (Annual)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Patrick Baiyu Xu Non-Executive Director Jun 2022

Mr Patrick Baiyu Xu

Non-Executive Director

Mr Xu has over ten years of commercial banking experience with specific experience in property finance, cash flow lending, as well as trade and working capital funding.

Mr Simon Francis Rowe Non-Executive Director Aug 2021

Mr Simon Francis Rowe

Non-Executive Director

Mr Rowe is currently the Supply Chain Transformation & Operations Leader ANZ at Kimberly-Clark - a Fortune 500 personal care company. Prior to that, Simon has held associate director and senior manager level roles within KPMG and EY advisory focusing on operational transformation and optimization.

Dr Robert (Rob) Alexander Jenny Executive Director Aug 2021

Dr Robert (Rob) Alexander Jenny

Executive Director

Dr Jenny is currently an executive at Cannvalate - an Australian medicinal cannabis services company - where he manages their business development activities in the Australian and New Zealand market. Rob has previously held management and research roles including at Ensign Laboratories - one of Australia's contract pharmaceutical manufacturers - Immunoglobal Group, and Monash University

Ms Louisa Ho Company Secretary Jun 2021
Mr Jarrod Travers White Chief Executive Officer May 2020
Mr Sonny Didugu Joint Company Secretary,Chief Operating Officer May 2020
Mr Steven Xiaobo XU Non-Executive Director Jan 2018

Mr Steven Xiaobo XU

Non-Executive Director

Mr Xu is the Managing Director of Une-Innovation Consulting Australia Pty Ltd and Founding Partner of INP Capital Inc which manages a series of venture capital funds. The venture capital funds invest in companies specialised in Medical/Healthcare, AI, Fintech and Industrial technology and Medical Cannabis across Australia, New Zealand, North America and Israel. He has over 15 years experience working at PricewaterhouseCoopers and listed companies in Australia and China. He specialises in financing, IPO and M&A activities in a range of sectors.

Nicholas Marshall Chief Financial Officer N/A

Director Interests

The current holdings of EPN directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Patrick Xu 03/06/2022 N/A 17,647,059 N/A N/A
Simon Rowe 31/12/2021 245,000 N/A N/A N/A
Steven XU 31/12/2021 243,334 1,587,302 N/A N/A
Robert (Rob) Jenny 01/08/2021 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Mar 25, 2022.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Jvt Holding Bv 5,555,556 2.49%
Superhero Nominees Pty Ltd <Client A/C> 4,158,522 1.87%
Barcoo Holdings Pty Ltd <Wyan Family Investments> 3,795,824 1.70%
Meta Growth Corp 2,942,489 1.32%
Sunset Capital Management Pty Ltd <Sunset Superfund A/C> 2,888,872 1.30%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 2,765,654 1.24%
Health360 Investment Management Inc 2,698,334 1.21%
Barcoo Holdings Pty Ltd <Maple Vntures> 2,438,341 1.09%
Mcann Investments Pty Ltd 2,000,000 0.90%
Dyamond Trading And Consulting Pty Ltd <Dyamond Family A/C> 2,000,000 0.90%
Mr George Daaboul 2,000,000 0.90%
Citicorp Nominees Pty Limited 1,734,463 0.78%
Une-Innovation Consulting Australia Pty Ltd 1,587,302 0.71%
Pears Daisley Pty Ltd <Daisley Pears A/C> 1,500,000 0.67%
Mr Nicholas Charles Deverell Pownall 1,450,000 0.65%
Sawfam Pty Ltd <Sawyer Super Fund A/C> 1,409,751 0.63%
Ms Meili Yang 1,300,000 0.58%
Tiger Pty Ltd 1,250,000 0.56%
HSBC Custody Nominees (Australia) Limited 1,193,709 0.54%
Agri Fibre Industries Pty Ltd 1,158,417 0.52%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 1,113 3,698 1,193 1,957 365 8,326

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Lands Between Pty Ltd 03/05/2022 17,647,059 7.34

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
03-05-22 Lands Between Pty Ltd 17,647,059 -- 7.34

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $0.125 30 June
EPN Historical Price Data (CSV)
Up to 20 years of EOD share price history
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.